Gabriel E. Kiss, an associate in Glaser Weil’s Corporate Department, practices a broad range of corporate law. Gabriel’s practice focuses on corporate issues and transactional matters involving large and small companies as well as strategic investors from a variety of industries.

Gabriel received his law degree as well as a business law certificate from the University of Southern California Gould School of Law. Prior to law school, Gabriel received his BA from UCLA, where he graduated magna cum laude.


Gabriel's recent notable experience includes his representation of: 

  • Wyatt Technology, a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories and services, in its $1.36 billion acquisition by Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software.
  • TriMed Inc., a global developer of market-leading orthopedic implants, in the sale of a majority interest to Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners.
  • INVO Bioscience, Inc. (Nasdaq: INVO), a global leader in expanding access to advanced fertility treatment, in an all-stock reverse merger agreement with NAYA Biosciences Inc.
  • Alumni Capital Management, an alternative investment manager, in the equity financings of NeuBase Therapeutics Inc. (NASDAQ: NBSE) and Motorsport Games Inc. (NASDAQ: MSGM).



University of Southern California Gould School of Law, J.D., 2021

University of California, Los Angeles, B.A., magna cum laude, 2017


  • California
Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.